about
[Treatment of patients with breathing disturbances during sleep in the II ENT Department Silesian Medical University Zabrze].Diagnostic contribution of cardiac magnetic resonance in patients with acute coronary syndrome and culprit-free angiograms.Comparison of coronary artery bypass grafting with percutaneous coronary intervention for unprotected left main coronary artery diseaseComparison of First- and Second-Generation Drug-Eluting Stents in an All-Comer Population of Patients with Diabetes Mellitus (from Katowice-Zabrze Registry).First- Versus Second-Generation Drug-Eluting Stents in Acute Coronary Syndromes (Katowice-Zabrze Registry).COPeptin for diagnosis and prediction in Acute Coronary Syndrome (COPACS) Study: design and objectives.Left atrial myxoma in a patient with a biventricular pacemaker.Copeptin: a new marker in cardiology.Performance of highly sensitive cardiac troponin T assay to detect ischaemia at PET-CT in low-risk patients with acute coronary syndrome: a prospective observational study.Direct Comparison of 4 Very Early Rule-Out Strategies for Acute Myocardial Infarction Using High-Sensitivity Cardiac Troponin I.Direct Admission Versus Interhospital Transfer for Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction.Second-generation drug-eluting stents in the elderly patients with acute coronary syndrome: the in-hospital and 12-month follow-up of the all-comer registry.Gender differences and bleeding complications after PCI on first and second generation DES.Clinical Significance of Viral Genome Persistence in the Myocardium of Patients with Dilated Cardiomyopathy.Common origin of all three coronary arteries from the right sinus of Valsalva - first case study accompanied by mitral valve prolapse and vein anomaly, second case study followed by successful percutaneous coronary intervention of right coronary art[Young patients after myocardial infarction--what could be done?].Analysis of myocardial infarction time course in women compared with men in Upper Silesia population in 30 day follow-up.[Hearing evaluation in patients suffering from hypercholesterolemia].Circulating endothelial progenitor cells are inversely correlated with in-stent restenosis in patients with non-ST-segment elevation acute coronary syndromes treated with EPC-capture stents (JACK-EPC trial).The influence of obstructive sleep breathing disturbances on echocardiographic and pulmonary haemodynamic parameters in patients with dilated cardiomyopathy.Randomized placebo controlled blinded study to assess valsartan efficacy in preventing left ventricle remodeling in patients with dual chamber pacemaker--Rationale and design of the trial.Optimal invasive strategy for multivessel coronary artery disease in elderly diabetic patients.Long-Term Percutaneous Coronary Intervention Outcomes of Patients with Chronic Kidney Disease in the Era of Second-Generation Drug-Eluting Stents.Prohormones in the Early Diagnosis of Cardiac Syncope.Effect of Definition on Incidence and Prognosis of Type 2 Myocardial Infarction.Early diagnosis of acute myocardial infarction in patients with mild elevations of cardiac troponin.Role of copeptin in dual-cardiac marker strategy for patients with chest pain presented to ED.Upgrade from ICD to CRT-D: clinical and haemodynamic impact of biventricular pacing in a patient with acquired long QT syndrome.Utilisation of bivalirudin and vascular closure devices for same-day discharge after percutaneous coronary and peripheral interventions.Impact of anaemia on long-term outcomes in patients treated with first- and second-generation drug-eluting stents; Katowice-Zabrze Registry.Combining High Sensitivity Cardiac Troponin I and Cardiac Troponin T in the Early Diagnosis of Acute Myocardial Infarction.Copeptin as a Prognostic Marker in Acute Chest Pain and Suspected Acute Coronary Syndrome.Prospective validation of prognostic and diagnostic syncope scores in the emergency department[The diagnostic value of virus serology in patients with non-ischemic systolic heart failure and parvovirus B19 infection].Combined Use of High-Sensitive Cardiac Troponin, Copeptin, and the Modified HEART Score for Rapid Evaluation of Chest Pain PatientsAnnual Trends in Total Ischemic Time and One-Year Fatalities: The Paradox of STEMI Network Performance AssessmentAcute Responses of Novel Cardiac Biomarkers to a 24-h Ultra-MarathonDiagnostic and prognostic value of QRS duration and QTc interval in patients with suspected myocardial infarctionCircadian, weekly, seasonal, and temperature-dependent patterns of syncope aetiology in patients at increased risk of cardiac syncope
P50
Q33233642-908162C6-5FB0-4608-901A-69C629242017Q35135842-6EDEAC95-AB5E-4C9F-9DB4-8FB0299119FBQ35648305-9F65B41A-27AD-43C1-8EA8-0DBE8C86A1D6Q36239147-86B5462E-6F71-4383-A55D-A0A3E4071742Q37021327-7F998DD8-C2C3-40A8-B4F6-4F6EE3D0B222Q37463800-2181238E-49DC-4AE1-B4FF-AA030600DCC1Q37584188-D6D3C61C-8752-411B-B8C4-B303A2878AE5Q38042281-1AD623F0-5113-4315-8644-B3F404F9BD69Q38374170-EFF57C74-4AD7-4028-8FD2-48898A801E53Q38379588-2BE3EA6D-6866-4DDE-BE24-3E3E25B864EDQ38952941-2A4C97C3-EE0E-41E1-B55C-AD108B943590Q39198400-0BCB47CF-89C1-494E-BA45-4B5F2511C495Q39546048-FBBE5B6A-2FFF-4AB8-A399-8083B4D546CDQ40931131-6A76AC44-BA47-41EC-8618-E169C2C0FF1BQ42290589-FA268721-3C46-44F8-A2B6-5B36BF4DA9A4Q42787627-43A9E059-A6EB-4E88-9F19-36974006FCB1Q43232629-934D7EFB-622F-4AD1-9117-3511FEB5FBC6Q44782857-DA080DED-EE20-4E65-ACD8-7342658A9546Q46119998-9396F540-6503-4DC7-A6FF-054E2B950ACAQ47953248-55C95863-49BC-4973-89F5-F6CFFAEAF170Q48237971-3093EF15-D30E-458D-83E5-A335716F7743Q48972969-FFA9DE38-799D-4B96-830B-824202A6306EQ49639946-5E13AD82-038C-4143-B730-D5E4EE5E3710Q49707707-E075732B-D9EE-4728-B725-C1F80CF76EC5Q49958752-06A13624-9C86-4D79-ACE7-9EB958860C75Q50217429-B10F4DB3-81F0-46D2-A06B-83AFF4E41673Q50938802-8631EE40-CEC2-4413-921D-CA70A71DB081Q51064183-8990FE3E-3036-41CD-A6F9-15B598A11998Q51624205-F1C999FD-26B1-4B62-A7F6-1C4B1E9A234CQ51642374-B177EF0D-5AE7-4DC0-AA77-261F43B1C522Q52565576-7587F74B-779D-4DA9-817C-69C22FA3DB86Q55002418-5503CA45-5763-41C0-B403-21CC836BF579Q57463841-010FDB7A-68E3-4763-A02C-8E3F61006F2EQ59593211-3675D7F9-0AB2-43C2-8AD9-F98B505F9719Q59809959-0DB93393-7DF9-49F5-A3E3-C6368007AE54Q61796437-B1CA2F67-8F31-435A-94CE-04A9D9798ADEQ61802397-C0655310-7FFC-460B-A30B-409C42BE8E65Q62128748-82826321-9E07-46F1-B84C-C8CF5342F0EEQ95725624-C776D964-639E-408C-8890-D56F23689624
P50
description
Polish cardiologist
@en
Pools arts
@nl
cairdeolaí Polannach
@ga
polski lekarz, kardiolog
@pl
name
Damian Kawecki
@ast
Damian Kawecki
@ca
Damian Kawecki
@cs
Damian Kawecki
@en
Damian Kawecki
@es
Damian Kawecki
@ga
Damian Kawecki
@gl
Damian Kawecki
@hr
Damian Kawecki
@hsb
Damian Kawecki
@it
type
label
Damian Kawecki
@ast
Damian Kawecki
@ca
Damian Kawecki
@cs
Damian Kawecki
@en
Damian Kawecki
@es
Damian Kawecki
@ga
Damian Kawecki
@gl
Damian Kawecki
@hr
Damian Kawecki
@hsb
Damian Kawecki
@it
prefLabel
Damian Kawecki
@ast
Damian Kawecki
@ca
Damian Kawecki
@cs
Damian Kawecki
@en
Damian Kawecki
@es
Damian Kawecki
@ga
Damian Kawecki
@gl
Damian Kawecki
@hr
Damian Kawecki
@hsb
Damian Kawecki
@it
P106
P1412
P1559
Damian Kawecki
@pl
P21
P214
59152682494523310334
P27
P31
P3124
P496
0000-0003-4445-9721
P734
P735
P7859
viaf-59152682494523310334